When standard protocols stopped working for my lymphoma, I researched dendritic cells therapy for cancer. In Germany, they've refined this treatment over decades with impressive results for blood cancers. What stood out was their detailed patient selection criteria - they were honest about who would likely benefit. The personalized vaccine created from my own cells felt like truly targeted medicine. My hematologist was skeptical at first but became a believer after seeing my scans improve without the harsh side effects of previous treatments. Now he recommends it to suitable patients.